Conference weeks are about what you can put in a tray, not what you can put on a slide.
AOFAS in Seattle this week did what AOFAS should: Stryker stitched Prophecy planning to Incompass total ankle and pushed connected limb frames, Treace widened past bunions into mid and hindfoot, and a string of extremity specialists cleared or launched plating, nails, and all-suture hand constructs.
Across the aisle, Synergy put two-year IDE superiority for Synergy Disc versus ACDF on the SMISS board, SIGNUS planted a first U.S. COSY occipito-cervical case, and CurveBeam cleared CT-based bone mineral density—the quiet enabler that wants to sit inside the scan surgeons already order.
Apollo’s roughly $20B conversation around J&J’s DePuy Synthes business kept circulating with no signature. Traditional U.S. early-stage implant venture printed almost nothing. That is not a dead market. It is a market that will pay for a cleared extremity SKU, a lordosis dataset, or a sterile-barrier fix, and will not pay for another elegant tray with no ASC utilization story.
Weekly Overview by Sector
Sector
Notable Move
Key Strategic Implication
Foot & Ankle / Extremities
Stryker Prophecy for Incomp...
